LRMR
Larimar Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenOct 22, 2026 1:54:16 PM EDT
2.30USD-5.165%(-0.12)732,341
Pre-marketOct 22, 2026 9:25:30 AM EDT
2.36USD-2.479%(-0.06)
LRMR Financials
In Q2 FY 2026 (ended ), Larimar Therapeutics, Inc. Common Stock (LRMR) reported net income of −$32.78M, operating cash flow of −$44.03M, and assets of $165.3M.
Loading financial statements…